Business
Rigel to Present at the Jefferies 2023 Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., May 31, 2023 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's
About this update from Rigel Pharmaceuticals, Inc.
[{"type":"text","content":"SOUTH SAN FRANCISCO, Calif., May 31, 2023 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, will present on Wednesday, June 7, 2023 at 2:30 p.m. ET at the Jefferies 2023 Global Healthcare Conference, being held June 7-9, 2023 in New York, NY.\nTo access the live and subsequent archived webcast, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.\nAbout RigelRigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.\nContact for Investors & Media: \nInvestors:Rigel Pharmaceuticals, [email protected]\nMedia: David RosenArgot [email protected]\n\n \n\n\n\n View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-to-present-at-the-jefferies-2023-global-healthcare-conference-301838057.html\nSOURCE Rigel Pharmaceuticals, Inc.","length":3152,"tagName":"div"}]